找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins; Ulf Grawunder,Stefan Barth Book 2017 Springer International Publishing A

[復制鏈接]
查看: 49026|回復: 42
樓主
發(fā)表于 2025-3-21 19:11:04 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins
編輯Ulf Grawunder,Stefan Barth
視頻videohttp://file.papertrans.cn/667/666181/666181.mp4
概述Offers cutting-edge information on the development of antibody drug conjugates and recombinant immunotoxins.Explores related basic biological and chemical technologies and promotes new developments to
叢書名稱Milestones in Drug Therapy
圖書封面Titlebook: Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins;  Ulf Grawunder,Stefan Barth Book 2017 Springer International Publishing A
描述.This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.. .The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology..
出版日期Book 2017
關鍵詞Antibody based cancer therapy; Antibody drug conjugates (ADC); Immunotoxin development; Pyrrolobenzodia
版次1
doihttps://doi.org/10.1007/978-3-319-46877-8
isbn_softcover978-3-319-83609-6
isbn_ebook978-3-319-46877-8Series ISSN 2296-6056 Series E-ISSN 2296-6064
issn_series 2296-6056
copyrightSpringer International Publishing AG 2017
The information of publication is updating

書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins影響因子(影響力)




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins影響因子(影響力)學科排名




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins網(wǎng)絡公開度




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins網(wǎng)絡公開度學科排名




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins被引頻次




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins被引頻次學科排名




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins年度引用




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins年度引用學科排名




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins讀者反饋




書目名稱Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:05:01 | 只看該作者
Milestones in Drug Therapyhttp://image.papertrans.cn/n/image/666181.jpg
板凳
發(fā)表于 2025-3-22 01:01:31 | 只看該作者
https://doi.org/10.1007/978-3-319-46877-8Antibody based cancer therapy; Antibody drug conjugates (ADC); Immunotoxin development; Pyrrolobenzodia
地板
發(fā)表于 2025-3-22 08:01:08 | 只看該作者
5#
發(fā)表于 2025-3-22 11:37:23 | 只看該作者
6#
發(fā)表于 2025-3-22 13:41:08 | 只看該作者
Chemical Assembly of Antibody-Drug Conjugates, over 60 are in clinical trials. Although many ADCs involve non-specific drug attachment via lysine and cysteine residues, the desire to produce homogeneous ADCs has led to the development of several site-specific chemical assembly strategies. The first site-specific ADCs are just beginning to enter
7#
發(fā)表于 2025-3-22 19:14:50 | 只看該作者
8#
發(fā)表于 2025-3-22 23:48:51 | 只看該作者
Stable and Homogeneous Drug Conjugation by Sequential Bis-Alkylation at Disulphide Bonds Using Bis-ion in ADC development is that much effort and time is needed to fully optimise the combination of antibody, linker and drug. New linker strategies are required to ensure that more homogeneous and stable ADCs can be produced with more predictable in vivo behaviour without the need for extensive re-o
9#
發(fā)表于 2025-3-23 03:14:38 | 只看該作者
10#
發(fā)表于 2025-3-23 08:49:12 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 22:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
北流市| 西盟| 肥乡县| 临湘市| 尚志市| 云龙县| 宜都市| 什邡市| 天门市| 满洲里市| 建德市| 闵行区| 平遥县| 苗栗县| 巴青县| 增城市| 黄山市| 临汾市| 黔西| 都兰县| 雷州市| 张家口市| 休宁县| 新龙县| 温州市| 泽州县| 甘德县| 开平市| 绥德县| 巴林左旗| 沈丘县| 麟游县| 遵化市| 布尔津县| 柯坪县| 上高县| 蒲城县| 嘉黎县| 曲阳县| 泗阳县| 宜章县|